278 related articles for article (PubMed ID: 19901246)
1. Determinants of survival in progressive multifocal leukoencephalopathy.
Marzocchetti A; Tompkins T; Clifford DB; Gandhi RT; Kesari S; Berger JR; Simpson DM; Prosperi M; De Luca A; Koralnik IJ
Neurology; 2009 Nov; 73(19):1551-8. PubMed ID: 19901246
[TBL] [Abstract][Full Text] [Related]
2. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
3. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.
Du Pasquier RA; Clark KW; Smith PS; Joseph JT; Mazullo JM; De Girolami U; Letvin NL; Koralnik IJ
J Neurovirol; 2001 Aug; 7(4):318-22. PubMed ID: 11517410
[TBL] [Abstract][Full Text] [Related]
4. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
[TBL] [Abstract][Full Text] [Related]
5. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
6. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.
Du Pasquier RA; Autissier P; Zheng Y; Jean-Jacques J; Koralnik IJ
AIDS; 2005 Dec; 19(18):2069-76. PubMed ID: 16284455
[TBL] [Abstract][Full Text] [Related]
7. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
[TBL] [Abstract][Full Text] [Related]
9. Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.
Grabowski MK; Viscidi RP; Margolick JB; Jacobson LP; Shah KV
J Med Virol; 2009 Jul; 81(7):1140-50. PubMed ID: 19475619
[TBL] [Abstract][Full Text] [Related]
10. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.
Marzocchetti A; Lima M; Tompkins T; Kavanagh DG; Gandhi RT; O'Neill DW; Bhardwaj N; Koralnik IJ
Virology; 2009 Jan; 383(2):173-7. PubMed ID: 19062062
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
[TBL] [Abstract][Full Text] [Related]
12. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
13. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y;
PLoS One; 2011; 6(6):e20967. PubMed ID: 21738597
[TBL] [Abstract][Full Text] [Related]
14. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Khanna N; Wolbers M; Mueller NJ; Garzoni C; Du Pasquier RA; Fux CA; Vernazza P; Bernasconi E; Viscidi R; Battegay M; Hirsch HH;
J Virol; 2009 May; 83(9):4404-11. PubMed ID: 19211737
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
[TBL] [Abstract][Full Text] [Related]
16. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
[TBL] [Abstract][Full Text] [Related]
18. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
[TBL] [Abstract][Full Text] [Related]
19. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.
Gheuens S; Bord E; Kesari S; Simpson DM; Gandhi RT; Clifford DB; Berger JR; Ngo L; Koralnik IJ
J Virol; 2011 Jul; 85(14):7256-63. PubMed ID: 21543472
[TBL] [Abstract][Full Text] [Related]
20. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
Tan CS; Bord E; Broge TA; Glotzbecker B; Mills H; Gheuens S; Rosenblatt J; Avigan D; Koralnik IJ
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):244-8. PubMed ID: 22549384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
